All In Biotech

Drug Trial Radar · NCT00000569

Lung Health Study II

The Chronic Obstructive Pulmonary Disease Early Intervention Trial

Last checked: Nov 20, 2026Latest source record: Nov 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,116 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,116

Actual

Start

Sep 1993

Primary completion

May 1999

Study completion May 1999

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Oct 28, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 69 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo.

Conditions

  • Lung Diseases
  • Lung Diseases, Obstructive
  • Chronic Obstructive Pulmonary Disease

Interventions

  • triamcinoloneDrug

    1200 micrograms of triamcinolone in daily divided doses

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.